TGA or the Therapeutic Goods Administration is reviewing complaints made against medical cannabis companies using non-compliant advertising.
According to a press release published by TGA on June 23rd, the review is meant to put an end to unlawful behavior and wrongful advertising that could potentially harm consumers. The compliance review undertaken considers a breach of regulations which includes companies that advertise:
- Medical cannabis products which have not satisfactorily met quality and safety standards
- Or publish information that promotes its use and/or supply
- Products with references to certain illnesses or conditions
TGA has already written to several entities and is reviewing complaints that pose an immediate risk to consumer health. This regulatory investigation is being undertaken just as the Therapeutic Goods Act tightens the quality requirements for medical cannabis imports.